New York Presbyterian Weill Cornell Medical Center is a clinical research site located in New York, New York, United States 10065.
Crixeo Health Trust Score: 72/100 (FAIR). This profile has not yet been claimed by the site owner.
New York Presbyterian Weill Cornell Medical Center has participated in 4 clinical trials with 3 currently active.
Therapeutic areas: Pancreatic Ductal Adenocarcinoma, Colorectal Cancer, KRAS G12D.
Sponsors: Elicio Therapeutics, Masonic Cancer Center, University of Minnesota, Treadwell Therapeutics, Inc.
Trust Score: 72/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
New York Presbyterian Weill Cornell Medical Center has a Crixeo Trust Score of 72/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
New York Presbyterian Weill Cornell Medical Center has 4 clinical trials on record, with 3 currently active. Their work covers Pancreatic Ductal Adenocarcinoma, Colorectal Cancer, KRAS G12D.
Yes — New York Presbyterian Weill Cornell Medical Center holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.